Table 3 Validity, reliability, and pre-test probability of TBNA outcome for diagnosing mediastinal and hilar adenopathies.
From: Validity and reliability of transbronchial needle aspiration for diagnosing mediastinal adenopathies
Pathology | Patients | Se | Sp | PPV | NPV*** | Accuracy |
|---|---|---|---|---|---|---|
Non-small cell lung carcinoma* | 280 | 68.3% | 100% | 100% | 9.5% | 69.3% |
Small cell lung carcinoma** | 74 | 93.2% | 100% | 100% | 16.7% | 93.2% |
Extrapulmonary carcinoma* | 44 | 69.8% | 100% | 100% | 7.1% | 70.5% |
Sarcoidosis* | 57 | 63.6% | 100% | 100% | 9.1% | 64.9% |
Tuberculosis* | 19 | 72.2% | 100% | 100% | 16.7% | 73.7% |
Lymphoma | 15 | 35.7% | 100% | 100% | 10.0% | 40.0% |
Anthracotic and reactive | 91 | 52.7% | - | 100% | - | 52.7% |
Total | 580 | 68.0% | 100% | 100% | 10.0% | 68.8% |